img

Global Hypertension and Heart Failure Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Hypertension and Heart Failure Drugs Market Insights, Forecast to 2034

Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to control HTN in CHF.
Market Analysis and InsightsGlobal Hypertension and Heart Failure Drugs Market
Global Hypertension and Heart Failure Drugs market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Hypertension and Heart Failure Drugs industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Hypertension and Heart Failure Drugs market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Hypertension and Heart Failure Drugs market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Menarini Group
Johnson & Johnson
Lupin
Boehringer Ingelheim
Novartis
Merck & Co
AstraZeneca
Pfizer, Inc
Sanofi SA
Dr. Reddy's Laboratories
Daiichi Sankyo Company Limited
Segment by Type
Diuretics
Beta Blockers
Ace Inhibitors
Alpha Blockers
Others

Segment by Application


Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Hypertension and Heart Failure Drugs introduction, etc. Hypertension and Heart Failure Drugs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Hypertension and Heart Failure Drugs
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Diuretics
1.2.3 Beta Blockers
1.2.4 Ace Inhibitors
1.2.5 Alpha Blockers
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Men
1.3.3 Women
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypertension and Heart Failure Drugs Market Perspective (2018-2033)
2.2 Global Hypertension and Heart Failure Drugs Growth Trends by Region
2.2.1 Hypertension and Heart Failure Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hypertension and Heart Failure Drugs Historic Market Size by Region (2018-2023)
2.2.3 Hypertension and Heart Failure Drugs Forecasted Market Size by Region (2024-2033)
2.3 Hypertension and Heart Failure Drugs Market Dynamics
2.3.1 Hypertension and Heart Failure Drugs Industry Trends
2.3.2 Hypertension and Heart Failure Drugs Market Drivers
2.3.3 Hypertension and Heart Failure Drugs Market Challenges
2.3.4 Hypertension and Heart Failure Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hypertension and Heart Failure Drugs by Players
3.1.1 Global Hypertension and Heart Failure Drugs Revenue by Players (2018-2023)
3.1.2 Global Hypertension and Heart Failure Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Hypertension and Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hypertension and Heart Failure Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Hypertension and Heart Failure Drugs Market Concentration Ratio
3.4.1 Global Hypertension and Heart Failure Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypertension and Heart Failure Drugs Revenue in 2022
3.5 Global Key Players of Hypertension and Heart Failure Drugs Head office and Area Served
3.6 Global Key Players of Hypertension and Heart Failure Drugs, Product and Application
3.7 Global Key Players of Hypertension and Heart Failure Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypertension and Heart Failure Drugs Breakdown Data by Type
4.1 Global Hypertension and Heart Failure Drugs Historic Market Size by Type (2018-2023)
4.2 Global Hypertension and Heart Failure Drugs Forecasted Market Size by Type (2024-2033)
5 Hypertension and Heart Failure Drugs Breakdown Data by Application
5.1 Global Hypertension and Heart Failure Drugs Historic Market Size by Application (2018-2023)
5.2 Global Hypertension and Heart Failure Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hypertension and Heart Failure Drugs Market Size (2018-2033)
6.2 North America Hypertension and Heart Failure Drugs Market Size by Type
6.2.1 North America Hypertension and Heart Failure Drugs Market Size by Type (2018-2023)
6.2.2 North America Hypertension and Heart Failure Drugs Market Size by Type (2024-2033)
6.2.3 North America Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
6.3 North America Hypertension and Heart Failure Drugs Market Size by Application
6.3.1 North America Hypertension and Heart Failure Drugs Market Size by Application (2018-2023)
6.3.2 North America Hypertension and Heart Failure Drugs Market Size by Application (2024-2033)
6.3.3 North America Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
6.4 North America Hypertension and Heart Failure Drugs Market Size by Country
6.4.1 North America Hypertension and Heart Failure Drugs Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Hypertension and Heart Failure Drugs Market Size by Country (2018-2023)
6.4.3 North America Hypertension and Heart Failure Drugs Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hypertension and Heart Failure Drugs Market Size (2018-2033)
7.2 Europe Hypertension and Heart Failure Drugs Market Size by Type
7.2.1 Europe Hypertension and Heart Failure Drugs Market Size by Type (2018-2023)
7.2.2 Europe Hypertension and Heart Failure Drugs Market Size by Type (2024-2033)
7.2.3 Europe Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
7.3 Europe Hypertension and Heart Failure Drugs Market Size by Application
7.3.1 Europe Hypertension and Heart Failure Drugs Market Size by Application (2018-2023)
7.3.2 Europe Hypertension and Heart Failure Drugs Market Size by Application (2024-2033)
7.3.3 Europe Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
7.4 Europe Hypertension and Heart Failure Drugs Market Size by Country
7.4.1 Europe Hypertension and Heart Failure Drugs Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Hypertension and Heart Failure Drugs Market Size by Country (2018-2023)
7.4.3 Europe Hypertension and Heart Failure Drugs Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hypertension and Heart Failure Drugs Market Size (2018-2033)
8.2 China Hypertension and Heart Failure Drugs Market Size by Type
8.2.1 China Hypertension and Heart Failure Drugs Market Size by Type (2018-2023)
8.2.2 China Hypertension and Heart Failure Drugs Market Size by Type (2024-2033)
8.2.3 China Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
8.3 China Hypertension and Heart Failure Drugs Market Size by Application
8.3.1 China Hypertension and Heart Failure Drugs Market Size by Application (2018-2023)
8.3.2 China Hypertension and Heart Failure Drugs Market Size by Application (2024-2033)
8.3.3 China Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Hypertension and Heart Failure Drugs Market Size (2018-2033)
9.2 Asia Hypertension and Heart Failure Drugs Market Size by Type
9.2.1 Asia Hypertension and Heart Failure Drugs Market Size by Type (2018-2023)
9.2.2 Asia Hypertension and Heart Failure Drugs Market Size by Type (2024-2033)
9.2.3 Asia Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
9.3 Asia Hypertension and Heart Failure Drugs Market Size by Application
9.3.1 Asia Hypertension and Heart Failure Drugs Market Size by Application (2018-2023)
9.3.2 Asia Hypertension and Heart Failure Drugs Market Size by Application (2024-2033)
9.3.3 Asia Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
9.4 Asia Hypertension and Heart Failure Drugs Market Size by Region
9.4.1 Asia Hypertension and Heart Failure Drugs Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Hypertension and Heart Failure Drugs Market Size by Region (2018-2023)
9.4.3 Asia Hypertension and Heart Failure Drugs Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Menarini Group
11.1.1 Menarini Group Company Details
11.1.2 Menarini Group Business Overview
11.1.3 Menarini Group Hypertension and Heart Failure Drugs Introduction
11.1.4 Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.1.5 Menarini Group Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Hypertension and Heart Failure Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.2.5 Johnson & Johnson Recent Developments
11.3 Lupin
11.3.1 Lupin Company Details
11.3.2 Lupin Business Overview
11.3.3 Lupin Hypertension and Heart Failure Drugs Introduction
11.3.4 Lupin Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.3.5 Lupin Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Hypertension and Heart Failure Drugs Introduction
11.4.4 Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Hypertension and Heart Failure Drugs Introduction
11.5.4 Novartis Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.5.5 Novartis Recent Developments
11.6 Merck & Co
11.6.1 Merck & Co Company Details
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Hypertension and Heart Failure Drugs Introduction
11.6.4 Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.6.5 Merck & Co Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Hypertension and Heart Failure Drugs Introduction
11.7.4 AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.7.5 AstraZeneca Recent Developments
11.8 Pfizer, Inc
11.8.1 Pfizer, Inc Company Details
11.8.2 Pfizer, Inc Business Overview
11.8.3 Pfizer, Inc Hypertension and Heart Failure Drugs Introduction
11.8.4 Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.8.5 Pfizer, Inc Recent Developments
11.9 Sanofi SA
11.9.1 Sanofi SA Company Details
11.9.2 Sanofi SA Business Overview
11.9.3 Sanofi SA Hypertension and Heart Failure Drugs Introduction
11.9.4 Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.9.5 Sanofi SA Recent Developments
11.10 Dr. Reddy's Laboratories
11.10.1 Dr. Reddy's Laboratories Company Details
11.10.2 Dr. Reddy's Laboratories Business Overview
11.10.3 Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Introduction
11.10.4 Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.10.5 Dr. Reddy's Laboratories Recent Developments
11.11 Daiichi Sankyo Company Limited
11.11.1 Daiichi Sankyo Company Limited Company Details
11.11.2 Daiichi Sankyo Company Limited Business Overview
11.11.3 Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Introduction
11.11.4 Daiichi Sankyo Company Limited Revenue in Hypertension and Heart Failure Drugs Business (2018-2023)
11.11.5 Daiichi Sankyo Company Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Diuretics
Table 3. Key Players of Beta Blockers
Table 4. Key Players of Ace Inhibitors
Table 5. Key Players of Alpha Blockers
Table 6. Key Players of Others
Table 7. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Hypertension and Heart Failure Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Hypertension and Heart Failure Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Hypertension and Heart Failure Drugs Market Share by Region (2018-2023)
Table 11. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Hypertension and Heart Failure Drugs Market Share by Region (2024-2033)
Table 13. Hypertension and Heart Failure Drugs Market Trends
Table 14. Hypertension and Heart Failure Drugs Market Drivers
Table 15. Hypertension and Heart Failure Drugs Market Challenges
Table 16. Hypertension and Heart Failure Drugs Market Restraints
Table 17. Global Hypertension and Heart Failure Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Hypertension and Heart Failure Drugs Revenue Share by Players (2018-2023)
Table 19. Global Top Hypertension and Heart Failure Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension and Heart Failure Drugs as of 2022)
Table 20. Global Hypertension and Heart Failure Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Hypertension and Heart Failure Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Hypertension and Heart Failure Drugs, Headquarters and Area Served
Table 23. Global Key Players of Hypertension and Heart Failure Drugs, Product and Application
Table 24. Global Key Players of Hypertension and Heart Failure Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hypertension and Heart Failure Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2024-2033)
Table 30. Global Hypertension and Heart Failure Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Hypertension and Heart Failure Drugs Revenue Share by Application (2018-2023)
Table 32. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Hypertension and Heart Failure Drugs Revenue Share by Application (2024-2033)
Table 34. North America Hypertension and Heart Failure Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Hypertension and Heart Failure Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Hypertension and Heart Failure Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Hypertension and Heart Failure Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Hypertension and Heart Failure Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Hypertension and Heart Failure Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Hypertension and Heart Failure Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Hypertension and Heart Failure Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Hypertension and Heart Failure Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Hypertension and Heart Failure Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Hypertension and Heart Failure Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Hypertension and Heart Failure Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Hypertension and Heart Failure Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Hypertension and Heart Failure Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Hypertension and Heart Failure Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Hypertension and Heart Failure Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Hypertension and Heart Failure Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Hypertension and Heart Failure Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Hypertension and Heart Failure Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Hypertension and Heart Failure Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Hypertension and Heart Failure Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Hypertension and Heart Failure Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Hypertension and Heart Failure Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Hypertension and Heart Failure Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Hypertension and Heart Failure Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 66. Menarini Group Company Details
Table 67. Menarini Group Business Overview
Table 68. Menarini Group Hypertension and Heart Failure Drugs Product
Table 69. Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 70. Menarini Group Recent Developments
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Hypertension and Heart Failure Drugs Product
Table 74. Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 75. Johnson & Johnson Recent Developments
Table 76. Lupin Company Details
Table 77. Lupin Business Overview
Table 78. Lupin Hypertension and Heart Failure Drugs Product
Table 79. Lupin Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 80. Lupin Recent Developments
Table 81. Boehringer Ingelheim Company Details
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Hypertension and Heart Failure Drugs Product
Table 84. Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 85. Boehringer Ingelheim Recent Developments
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Hypertension and Heart Failure Drugs Product
Table 89. Novartis Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 90. Novartis Recent Developments
Table 91. Merck & Co Company Details
Table 92. Merck & Co Business Overview
Table 93. Merck & Co Hypertension and Heart Failure Drugs Product
Table 94. Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 95. Merck & Co Recent Developments
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Hypertension and Heart Failure Drugs Product
Table 99. AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 100. AstraZeneca Recent Developments
Table 101. Pfizer, Inc Company Details
Table 102. Pfizer, Inc Business Overview
Table 103. Pfizer, Inc Hypertension and Heart Failure Drugs Product
Table 104. Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 105. Pfizer, Inc Recent Developments
Table 106. Sanofi SA Company Details
Table 107. Sanofi SA Business Overview
Table 108. Sanofi SA Hypertension and Heart Failure Drugs Product
Table 109. Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 110. Sanofi SA Recent Developments
Table 111. Dr. Reddy's Laboratories Company Details
Table 112. Dr. Reddy's Laboratories Business Overview
Table 113. Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Product
Table 114. Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 115. Dr. Reddy's Laboratories Recent Developments
Table 116. Daiichi Sankyo Company Limited Company Details
Table 117. Daiichi Sankyo Company Limited Business Overview
Table 118. Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Product
Table 119. Daiichi Sankyo Company Limited Revenue in Hypertension and Heart Failure Drugs Business (2018-2023) & (US$ Million)
Table 120. Daiichi Sankyo Company Limited Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Hypertension and Heart Failure Drugs Market Share by Type: 2022 VS 2033
Figure 3. Diuretics Features
Figure 4. Beta Blockers Features
Figure 5. Ace Inhibitors Features
Figure 6. Alpha Blockers Features
Figure 7. Others Features
Figure 8. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Hypertension and Heart Failure Drugs Market Share by Application: 2022 VS 2033
Figure 10. Men Case Studies
Figure 11. Women Case Studies
Figure 12. Hypertension and Heart Failure Drugs Report Years Considered
Figure 13. Global Hypertension and Heart Failure Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Hypertension and Heart Failure Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Hypertension and Heart Failure Drugs Market Share by Region: 2022 VS 2033
Figure 16. Global Hypertension and Heart Failure Drugs Market Share by Players in 2022
Figure 17. Global Top Hypertension and Heart Failure Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension and Heart Failure Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Hypertension and Heart Failure Drugs Revenue in 2022
Figure 19. North America Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
Figure 21. North America Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
Figure 22. North America Hypertension and Heart Failure Drugs Market Share by Country (2018-2033)
Figure 23. United States Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Hypertension and Heart Failure Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
Figure 27. Europe Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
Figure 28. Europe Hypertension and Heart Failure Drugs Market Share by Country (2018-2033)
Figure 29. Germany Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Hypertension and Heart Failure Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
Figure 37. China Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
Figure 38. Asia Hypertension and Heart Failure Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
Figure 40. Asia Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
Figure 41. Asia Hypertension and Heart Failure Drugs Market Share by Region (2018-2033)
Figure 42. Japan Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Country (2018-2033)
Figure 52. Brazil Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Hypertension and Heart Failure Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Menarini Group Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 60. Lupin Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 62. Novartis Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 63. Merck & Co Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 64. AstraZeneca Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 65. Pfizer, Inc Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 66. Sanofi SA Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 67. Dr. Reddy's Laboratories Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 68. Daiichi Sankyo Company Limited Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries